THERATECHNOLOGIES INC.

(TH)
  Rapport
Temps Différé Toronto Stock Exchange  -  21:59 09/08/2022
2.800 CAD   -0.36%
02/08Theratechnologies fera une présentation à la 42e conférence annuelle sur la croissance de Canaccord Genuity
GL
28/07Theratechnologies déclare que les données sur Trogarzo présentées à AIDS 2022 montrent "le potentiel d'amélioration des régimes de traitement".
MT
28/07Les données sur Trogarzo(MD) présentées à la conférence AIDS 2022 par Theratechnologies démontrent la possibilité d'améliorer les schémas thérapeutiques
GL
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur THERATECHNOLOGIES INC.
02/08Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
28/07Theratechnologies Says Trogarzo Data at AIDS 2022 Shows "Potential for Improved Treatme..
28/07Theratechnologies Says Trogarzo Clinical Data Shows Potential for Improved HIV Treatmen..
28/07Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Re..
28/07Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Re..
28/07Theratechnologies Closes US$40 Million Funding Under Credit Agreement with Marathon Ass..
28/07Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Cr..
28/07Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Cr..
20/07THERATECHNOLOGIES : Announces Binding Commitment for a Non-Dilutive Term Loan of up to $10..
19/07Theratechnologies Inc. Announces Binding Commitment for A Non-Dilutive Term Loan of Up ..
14/07SECTOR UPDATE : Health Care Stocks Unable to Climb Back to Positive Ground
14/07THERATECHNOLOGIES : Fiscal Q2 Earnings Snapshot
14/07TRANSCRIPT : Theratechnologies Inc., Q2 2022 Earnings Call, Jul 14, 2022
14/07Theratechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months E..
14/07Theratechnologies Reports Q2 2022 Results, Provides Update on Dose Escalation Portion o..
14/07Theratechnologies Inc. Provides Earnings Guidance for the Fiscal Year 2022
14/07THERATECHNOLOGIES BRIEF : Also Citing TH1902 Basket Trial Initiated; Binding Commitment fo..
14/07THERATECHNOLOGIES BRIEF : Reporting Q2 2022 Consolidated Sales Growth of 8.3% to US$19.3 m..
14/07THERATECHNOLOGIES BRIEF : Citing Year-to-Date Revenue Growth of 13.9% or US$37.8 million; ..
14/07Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results a..
14/07Theratechnologies Confirms Safety Profile of Cancer Drug Candidate in First-in-Human Tr..
14/07THERATECHNOLOGIES BRIEF : Provides Update on Dose Escalation Portion of Fast Track Designa..
14/07Theratechnologies Inc. Provides Update on the Dose Escalation Portion of Fast Track Des..
14/07Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designat..
14/07Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designat..
14/07NORTH AMERICAN MORNING BRIEFING : Bank Earnings -2-
13/07THERATECHNOLOGIES : Announces Binding Commitment for a Non-Dilutive Term Loan of up to $10..
13/07CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 millio..
13/07Theratechnologies Details Binding Commitment for a Non-Dilutive Term Loan of Up to US$1..
13/07THERATECHNOLOGIES BRIEF : Adds Initial Draw of US$40 Million Will Retire $30 Million of th..
13/07THERATECHNOLOGIES BRIEF : Says Financing Will "Significantly Strengthen the Balance Sheet ..
13/07THERATECHNOLOGIES BRIEF : Details Binding Commitment for a Non-Dilutive Term Loan of Up to..
13/07Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $1..
12/07CQDM, Quebec Breast Cancer Foundation,Theratechnologies, Fund $2 Million For Research t..
12/07CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 millio..
12/07CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 millio..
07/07CORRECTION : -- Theratechnologies Brief: To Announce Second Quarter 2022 Financial Results..
07/07Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Busines..
07/07THERATECHNOLOGIES BRIEF : Provides Business Update
07/07Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Busines..
31/05Theratechnologies Announces New Head of Investor Relations
31/05Theratechnologies Inc. Announces Elif Mcdonald as New Head of Investor Relations
10/05Appointments in Conjunction With Theratechnologies Annual Meeting
10/05Appointments in Conjunction With Theratechnologies Annual Meeting
10/05Theratechnologies Initiates Basket Portion of TH1902 First-in-Human Study in Advanced R..
10/05Theratechnologies Initiates Basket Portion of TH1902 First-in-Human Study in Advanced R..
10/05Theratechnologies Inc. Initiates Basket Portion of Th1902 First-In-Human Study in Advan..
28/04THERATECHNOLOGIES : MATERIAL CHANGE REPORT - Form 6-K
27/04Theratechnologies to Focus Commercialization Activities on the North American Territory
27/04THERATECHNOLOGIES BRIEF : Says To Focus Its Commercialization Activities on the North Amer..
27/04Theratechnologies to Focus Its Commercialization Activities on the North American Terri..
25/04Theratechnologies to Present at Bloom Burton & Co. Healthcare Investor Conference 2022
25/04Theratechnologies to Present at Bloom Burton & Co. Healthcare Investor Conference 2022
14/04THERATECHNOLOGIES : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K
14/04THERATECHNOLOGIES : (AMENDING AND RESTATING A SHAREHOLDER RIGHTS PLAN AGREEMENT - Form 6-K
13/04TRANSCRIPT : Theratechnologies Inc., Q1 2022 Earnings Call, Apr 13, 2022
13/04Theratechnologies Reports Q1 Revenue of US$18.557 Million, Provides 2022 Revenue Guidan..
13/04Theratechnologies Inc. Reports Earnings Results for the First Quarter Ended February 28..
13/04THERATECHNOLOGIES : Fiscal Q1 Earnings Snapshot
13/04THERATECHNOLOGIES : Interim Consolidated Financial Statements (In thousands of United Stat..
13/04Theratechnologies Inc. Affirmes Revenue Guidance for Full Fiscal 2022
13/04THERATECHNOLOGIES BRIEF : Or Growth of Commercial Portfolio to be in the Range of 13-20% V..
13/04THERATECHNOLOGIES BRIEF : Affirms fiscal 2022 revenue to be in the range of US$79 million ..
13/04THERATECHNOLOGIES BRIEF : Says Onboarding of commercial field force ongoing and to be full..
13/04THERATECHNOLOGIES BRIEF : Consolidated Revenue for Q1 was US$18,557,000 compared to $15,43..
13/04Theratechnologies Reports Financial Results for First Quarter Fiscal 2022 and Provides ..
08/04Theratechnologies Presents New In Vivo TH1902 Preclinical Data at AACR Annual Meeting 2..
08/04Theratechnologies Presents New In Vivo TH1902 Preclinical Data Demonstrating Tumor Grow..
31/03Theratechnologies to Announce Financial Results for Its First Quarter 2022
08/03Theratechnologies to Present Three Posters at AACR
08/03THERATECHNOLOGIES BRIEF : Says To Present Three Posters at AACR
08/03THERATECHNOLOGIES BRIEF : Adds This Will Include New In Vivo TH1902 Preclinical Data Demon..
08/03Theratechnologies to Present Three Posters at AACR Including New In Vivo TH1902 Preclin..
24/02THERATECHNOLOGIES : Fiscal Q4 Earnings Snapshot
24/02Theratechnologies Reports Q4 Revenue US$18.754 Millon; Announces Revenue Guidance of US..
1  2  3  4  5  6  7  8  9Suiv.
Prochain événement sur THERATECHNOLOGIES INC.